Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Padsevonil interaction study with ethanol or cannabidiol in healthy adults
NL-OMON49954Active, not recruiting
- Sponsor
- UCB
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of padsevonil, ethanol and cannabidiol in epilepsy and Focal Onset Epilepsy (4 arms), sponsored by UCB. Primary endpoints: Smooth pursuit eye movements, Padsevonil Cmax and 3 more. Started Jul 2019; status: active, not recruiting.
02
Drugs
padsevonilethanolcannabidiol
03
Conditions
epilepsyFocal Onset Epilepsy
Beyond the preview
Go deeper on NL-OMON49954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49954.